PD2-39208-89906
2 vaccinations
3 coded responses
19 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 064 / CT
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-11
-
2021-01-18
Survey response — day 21, dose 1MedDRA: Blepharitis, Eyelid rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Eyelid rash ? BlepheritisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-02-01
- 2021-02-04
- 2021-02-11
- 2021-02-18
-
2021-02-25
Survey response — day 35, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Rash has been ongoing since December/January forgot to report.Noted to neck and faceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-04
-
2021-04-07
Call successfulParticipant prefers to complete VAERS report online
- 2021-04-22
- 2021-07-22
-
2022-01-21
Survey response — 12 months, dose 2MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnant · Healthcare visit (other): OB outpatient visitMedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 2 — day 21, dose 1
Symptoms: Eyelid rash ? Blepheritis
Release 4 — day 35, dose 2
Symptoms: Rash has been ongoing since December/January forgot to report.Noted to neck and face
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Blepharitis | ✓ | ✓ | ✓ |
| SD | Eyelid rash | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release